For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $292.78 in the prior trading day, United Therapeutics Corp (NASDAQ: UTHR) closed at $278.89, down -4.74%. In other words, the price has decreased by -$4.74 from its previous closing price. On the day, 0.59 million shares were traded. UTHR stock price reached its highest trading level at $287.44 during the session, while it also had its lowest trading level at $269.925.
Ratios:
Our goal is to gain a better understanding of UTHR by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.83 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.62. For the most recent quarter (mrq), Quick Ratio is recorded 5.03 and its Current Ratio is at 5.25. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on July 11, 2024, Downgraded its rating to Equal-Weight and sets its target price to $321 from $310 previously.
On February 12, 2024, Goldman Upgraded its rating to Neutral which previously was Sell and also upped its target price recommendation from $213 to $215.
On February 05, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $330.Leerink Partners initiated its Outperform rating on February 05, 2024, with a $330 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 07 ’25 when DWEK RAYMOND sold 4,000 shares for $284.55 per share. The transaction valued at 1,138,200 led to the insider holds 1,750 shares of the business.
RAYMOND DWEK bought 4,000 shares of UTHR for $1,138,200 on Apr 07 ’25. On Apr 03 ’25, another insider, MAHON PAUL A, who serves as the EVP & GENERAL COUNSEL of the company, sold 11,000 shares for $306.18 each. As a result, the insider received 3,367,984 and left with 36,781 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UTHR now has a Market Capitalization of 12525563904 and an Enterprise Value of 10206615552. As of this moment, United’s Price-to-Earnings (P/E) ratio for their current fiscal year is 11.34, and their Forward P/E ratio for the next fiscal year is 9.63. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.54. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.35 while its Price-to-Book (P/B) ratio in mrq is 1.94. Its current Enterprise Value per Revenue stands at 3.547 whereas that against EBITDA is 6.72.
Stock Price History:
The Beta on a monthly basis for UTHR is 0.59, which has changed by 0.1990627 over the last 52 weeks, in comparison to a change of 0.028231144 over the same period for the S&P500. Over the past 52 weeks, UTHR has reached a high of $417.82, while it has fallen to a 52-week low of $230.39. The 50-Day Moving Average of the stock is -14.71%, while the 200-Day Moving Average is calculated to be -19.56%.
Shares Statistics:
The stock has traded on average 480.83K shares per day over the past 3-months and 524220 shares per day over the last 10 days, according to various share statistics. A total of 44.83M shares are outstanding, with a floating share count of 44.09M. Insiders hold about 1.83% of the company’s shares, while institutions hold 99.60% stake in the company. Shares short for UTHR as of 1741910400 were 1826411 with a Short Ratio of 3.56, compared to 1739491200 on 2065951. Therefore, it implies a Short% of Shares Outstanding of 1826411 and a Short% of Float of 5.35.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
